Trump's drug pricing order threatens Roche's $50 billion US investment plans, company says
ReutersMay 14, 2025 2:01 PM
LONDON, May 14 (Reuters) - U.S. President Donald Trump's executive order on drug pricing threatens Roche's ROG.S planned $50 billion investment in the United States, the company said on Wednesday.
Trump's order, signed Monday, directs pharmaceutical companies drugmakers to lower prices of brand-name medicines to align with those in other wealthy nations. Analysts and legal experts say the policy would be difficult to implement.
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Related Articles
Alibaba (BABA) Q4 2024 Earnings Preview: Will the Chinese Tech Rally Continue?
Alibaba will report its fourth quarterly earnings for this fiscal year on Thursday, after the bell. The stock has been performing solidly in the past twelve months with 55% increase, mostly driven by the company’s AI initiatives and recovery in the consumer sentiment in China. Tomorrow we will...TradingKey
15 hours ago
The Tariff Window Is Open — And So Is a Rally Opportunity
TradingKey - Markets got a shot of optimism this week following a surprise move by the U.S. and China: Both sides agreed to cut tariffs and head back to the negotiating table, setting up a highly anticipated 90-day window for trade talks.TradingKey
16 hours ago
[Reuters Analysis] How China's chip equipment manufacturing sector stacks up
BEIJING, May 14 (Reuters) - SiCarrier, a Chinese chip equipment maker with close links to Huawei, has created a stir with the breadth of its planned product range.Its efforts to become a one-stop shop for all tools needed to semiconductors illustrate how the sector - st...Reuters
Wed, May 14
Buffett’s Billion-Yen Bet: Why Global Capital Is Flowing Into Japan
TradingKey - Since April, the Nikkei 225 has surged from 32,000 to nearly 38,000 points—a 15% gain that sharply outpaces the S&P 500’s performance over the same period. Beyond the uptick in local investor engagement, global funds have also renewed their interest in Japan’s markets.TradingKey
Fri, May 9
